Anand Patel, Assistant Professor of Medicine; Medical Director, Inpatient Leukemia Service

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    AbbVie
    Topic:
    Advisory Board
    Date added:
    05/04/2023
    Date updated:
    04/04/2024
    Relationship end date:
    03/25/2023
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Bristol Myers Squibb
    Topic:
    Advisory Board
    Date added:
    05/04/2023
    Date updated:
    04/04/2024
    Relationship end date:
    12/10/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Pfizer
    Topic:
    research funding to institution for trial
    Date added:
    05/04/2023
    Date updated:
    04/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Kronos Bio
    Topic:
    research funding to institution for trial
    Date added:
    05/04/2023
    Date updated:
    04/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Sumitumo
    Topic:
    research funding to institution for trial
    Date added:
    05/04/2023
    Date updated:
    04/04/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Sobi
    Topic:
    Advisory Board
    Date added:
    04/04/2024
    Date updated:
    04/04/2024
    Relationship end date:
    12/08/2023
Return to Cellular Therapy in Hematology and Oncology: Expert Guidance for Clinical Practice